166 related articles for article (PubMed ID: 26711748)
1. C646, a Novel p300/CREB-Binding Protein-Specific Inhibitor of Histone Acetyltransferase, Attenuates Influenza A Virus Infection.
Zhao D; Fukuyama S; Sakai-Tagawa Y; Takashita E; Shoemaker JE; Kawaoka Y
Antimicrob Agents Chemother; 2015 Dec; 60(3):1902-6. PubMed ID: 26711748
[TBL] [Abstract][Full Text] [Related]
2. The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.
Jones JC; Marathe BM; Vogel P; Gasser R; Najera I; Govorkova EA
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193653
[TBL] [Abstract][Full Text] [Related]
3. Insights into intermolecular interactions, electrostatic properties and the stability of C646 in the binding pocket of p300 histone acetyltransferase enzyme: a combined molecular dynamics and charge density study.
Sivanandam M; Saravanan K; Kumaradhas P
J Biomol Struct Dyn; 2018 Sep; 36(12):3246-3264. PubMed ID: 28948877
[TBL] [Abstract][Full Text] [Related]
4. An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells.
Gu ML; Wang YM; Zhou XX; Yao HP; Zheng S; Xiang Z; Ji F
Oncol Rep; 2016 Nov; 36(5):2763-2770. PubMed ID: 27633918
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
6. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
[TBL] [Abstract][Full Text] [Related]
7. Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.
Ji Z; Clark RF; Bhat V; Matthew Hansen T; Lasko LM; Bromberg KD; Manaves V; Algire M; Martin R; Qiu W; Torrent M; Jakob CG; Liu H; Cole PA; Marmorstein R; Kesicki EA; Lai A; Michaelides MR
Bioorg Med Chem Lett; 2021 May; 39():127854. PubMed ID: 33631370
[TBL] [Abstract][Full Text] [Related]
8. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
[TBL] [Abstract][Full Text] [Related]
9. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
11. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe.
Oike T; Komachi M; Ogiwara H; Amornwichet N; Saitoh Y; Torikai K; Kubo N; Nakano T; Kohno T
Radiother Oncol; 2014 May; 111(2):222-7. PubMed ID: 24746574
[TBL] [Abstract][Full Text] [Related]
12. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
Wang YM; Gu ML; Meng FS; Jiao WR; Zhou XX; Yao HP; Ji F
Int J Oncol; 2017 Dec; 51(6):1860-1868. PubMed ID: 29075795
[TBL] [Abstract][Full Text] [Related]
13. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
Ma Q; Huang W; Zhao J; Yang Z
J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
[TBL] [Abstract][Full Text] [Related]
14.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses.
Aggarwal M; Leser GP; Lamb RA
J Virol; 2020 Feb; 94(6):. PubMed ID: 31896588
[TBL] [Abstract][Full Text] [Related]
16. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
17. Changing the selectivity of p300 by acetyl-CoA modulation of histone acetylation.
Henry RA; Kuo YM; Bhattacharjee V; Yen TJ; Andrews AJ
ACS Chem Biol; 2015 Jan; 10(1):146-56. PubMed ID: 25325435
[TBL] [Abstract][Full Text] [Related]
18. Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus.
Wang Y; Yan W; Chen Q; Huang W; Yang Z; Li X; Wang X
Biomed Pharmacother; 2017 Mar; 87():583-588. PubMed ID: 28081470
[TBL] [Abstract][Full Text] [Related]
19. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
20. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]